Roche Pharmaceuticals A/S: Financial statements 2016
CVR: 25230515
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 869,907,000 and a net result of DKK 25,476,000 compared with DKK 29,179,000 the year before. That is a decrease of 2.7% compared with the year before. The profit margin was 2.9%. Equity in the 2016 report amounted to DKK 124,881,000. The solvency ratio was 40.1%. The company had 125 employees in the financial year.
- Revenue
- DKK 869,907,000
- Gross Profit
- DKK 146,478,000
- Profit/Loss
- DKK 25,476,000
- Equity
- DKK 124,881,000
- Total Assets
- DKK 311,642,000
- Employees
- 125
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 869.9 mio. | 146.5 mio. | 25.5 mio. | 124.9 mio. | 125 |
| 2015 | 893.7 mio. | 161.1 mio. | 29.2 mio. | 129.4 mio. | 111 |
| 2014 | 839.9 mio. | 144.3 mio. | 26.7 mio. | 100.2 mio. | 103 |
| 2013 | 689.8 mio. | 128.9 mio. | 14.5 mio. | 88.6 mio. | 103 |
Official annual report
Find more companies like Roche Pharmaceuticals A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
Roche Pharmaceuticals A/S has published its annual report for 2015. Revenue came to DKK 893,694,000, and the net result was DKK 29,179,000.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.